0001104659-22-059497.txt : 20220512 0001104659-22-059497.hdr.sgml : 20220512 20220512164124 ACCESSION NUMBER: 0001104659-22-059497 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20220509 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220512 DATE AS OF CHANGE: 20220512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AdaptHealth Corp. CENTRAL INDEX KEY: 0001725255 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 823677704 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38399 FILM NUMBER: 22918533 BUSINESS ADDRESS: STREET 1: 220 WEST GERMANTOWN PIKE STREET 2: SUITE 250 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 BUSINESS PHONE: 610-630-6357 MAIL ADDRESS: STREET 1: 220 WEST GERMANTOWN PIKE STREET 2: SUITE 250 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 FORMER COMPANY: FORMER CONFORMED NAME: DFB Healthcare Acquisitions Corp. DATE OF NAME CHANGE: 20171213 8-K 1 tm2215133d2_8k.htm 8-K FORM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 9, 2022

AdaptHealth Corp.

(Exact name of registrant as specified in its charter)

Delaware		001-38399		82-3677704
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

220 West Germantown Pike, Suite 250 Plymouth Meeting, PA		19462
(Address of principal executive offices)		(Zip Code)

(610) 630-6357
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.0001 per share	AHCO	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 1.01 Entry into a Material Definitive Agreement.

On May 9, 2022, AdaptHealth LLC (“AdaptHealth”), a Delaware limited liability company and wholly owned indirect subsidiary of AdaptHealth Corp. (the “Company”), entered into that certain Consent Agreement (the “Consent Agreement”) with respect to the Credit Agreement, dated as of January 20, 2021 (as amended, restated, increased, extended, supplemented or otherwise modified from time to time), by and among AdaptHealth, the guarantors named therein, Regions Bank as administrative agent and collateral agent and the lenders party thereto). The Consent Agreement expressly permits AdaptHealth to make dividends to effect the Company’s previously announced stock repurchase program for up to $200 million of the Company’s common stock.

The foregoing description of the Consent Agreement does not purport to be complete and is qualified in its entirety by the full text thereof, which is filed as Exhibit 10.1 hereto and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d)

Exhibits

10.1	Consent Agreement dated as of May 9, 2022, among AdaptHealth LLC, the guarantors named therein, Regions Bank as administrative agent and collateral agent and the lenders party thereto.

104	The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	AdaptHealth Corp.

	By:	/s/ Jason Clemens
		Name:	Jason Clemens
		Title:	Chief Financial Officer

Dated: May 12, 2022

EX-10.1 2 tm2215133d2_ex10-1.htm EXHIBIT 10.1

Exhibit 10.1

CONSENT AGREEMENT

THIS CONSENT AGREEMENT (this “Agreement”) dated as of May 9, 2022, related to the Credit Agreement referenced below is by and among ADAPTHEALTH INTERMEDIATE HOLDCO LLC, a Delaware limited liability company (“Intermediate Holdings”), ADAPTHEALTH LLC, a Delaware limited liability company (the “Borrower”), certain Subsidiaries of the Borrower from time to time party thereto, as Guarantors, the Lenders from time to time party thereto, and REGIONS BANK, as administrative agent (in such capacity, the “Administrative Agent”).

W I T N E S S E T H

WHEREAS, revolving credit and term loan facilities have been extended to the Borrower pursuant to that certain Credit Agreement dated as of January 20, 2021 (as amended, restated, increased, extended, supplemented or otherwise modified from time to time, the “Credit Agreement”) by and among the Borrower, Intermediate Holdings, the Guarantors identified therein, the Lenders identified therein and the Administrative Agent and Collateral Agent; and

WHEREAS, the Borrower has informed the Lenders that (a) the board of directors of AdaptHealth Corp. has authorized the repurchase of shares of its Capital Stock pursuant to terms and conditions determined by the board of directors in good faith by written consent dated as of the date hereof (the “2022 Repurchase Transactions”) and (b) in order to fund the 2022 Repurchase Transactions, the Loan Parties intend to make Restricted Payments to AdaptHealth Corp. from time to time on or after the Effective Date in an aggregate amount not to exceed $200,000,000 (the “Specified Distributions”).

NOW, THEREFORE, IN CONSIDERATION of the premises and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

1.            Defined Terms. Capitalized terms used herein but not otherwise defined herein shall have the meanings provided to such terms in the Credit Agreement.

2.            Consent to Specified Distributions. Notwithstanding anything to the contrary in the Credit Agreement (including Section 8.6 of the Credit Agreement), the Required Lenders hereby consent (a) to the Specified Distributions and (b) agree that the calculation of Excess Cash Flow shall be reduced by the amount of Specified Distributions made in any applicable period. This consent is a one-time consent and shall be automatically and irrevocably effective only in this specific instance.

3.            Conditions Precedent. This Agreement shall become effective as of the date hereof (the “Effective Date”) upon receipt by the Administrative Agent of executed counterparts of this Agreement properly executed by an Authorized Officer of each Loan Party, the Required Lenders and the Administrative Agent.

4.            Agreement is a “Loan Document”. This Agreement is a Loan Document and all references to a “Loan Document” in the Credit Agreement and the other Loan Documents (including, without limitation, all such references in the representations and warranties in the Credit Agreement and the other Loan Documents) shall be deemed to include this Agreement.

5.            Representations and Warranties; No Default. Each Loan Party represents and warrants to the Administrative Agent and the Lenders that, on and as of the date hereof, immediately after giving effect to this Agreement, (a) the representations and warranties contained in Section 6 of the Credit Agreement and in the other Loan Documents are true and correct in all material respects (except to the extent such representation or warranty is already qualified by materiality in which case such representation and warranty is true and correct in all respects) on and as of the date hereof, except to the extent such representations and warranties specifically refer to an earlier date, in which case such representations and warranties are true and correct in all material respects (except to the extent such representation or warranty is already qualified by materiality in which case such representation and warranty is true and correct in all respects) on and as of such earlier date, and (b) no event has occurred and is continuing which constitutes an Event of Default or a Default.

6.            Reaffirmation of Obligations. Each Loan Party (a) acknowledges and consents to all of the terms and conditions of this Agreement, (b) affirms all of its obligations under the Loan Documents and (c) agrees that this Agreement and all documents, agreements and instruments executed in connection with this Agreement do not operate to reduce or discharge such Loan Party’s obligations under the Loan Documents.

7.            Reaffirmation of Security Interests. Each Loan Party (a) affirms that each of the Liens granted in or pursuant to the Loan Documents are valid and subsisting and (b) agrees that this Agreement and all documents, agreements and instruments executed in connection with this Agreement do not in any manner impair or otherwise adversely affect any of the Liens granted in or pursuant to the Loan Documents.

8.            No Other Changes. Except as modified hereby, all of the terms and provisions of the Loan Documents shall remain in full force and effect.

9.            Counterparts/Facsimile. This Agreement may be executed in counterparts (and by different parties hereto in different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. Delivery of an executed counterpart of a signature page of this Agreement by telecopy or other electronic imaging means (e.g. “pdf” or “tif” format) shall be effective as delivery of a manually executed counterpart of this Agreement.

10.          Governing Law. This Agreement shall be deemed to be a contract made under, and for all purposes shall be construed in accordance with, the laws of the State of New York.

[SIGNATURE PAGES FOLLOW]

2

IN WITNESS WHEREOF, each of the parties hereto has caused a counterpart of this Second Agreement to be duly executed and delivered as of the date first above written.

BORROWER:	ADAPTHEALTH LLC,
	a Delaware limited liability company

	By:	/s/ Christopher J. Joyce
	Name:	Christopher J. Joyce
	Title:	Vice President and Secretary

[SIGNATURE PAGES CONTINUE]

ADAPTHEALTH LLC
CONSENT AGREEMENT

GUARANTORS:	ACTIVSTYLE, LLC, a Minnesota limited liability company
	ADAPTHEALTH INTERMEDIATE HOLDCO LLC, a Delaware limited liability company
	ADAPTHEALTH - MISSOURI LLC, a Missouri limited liability company
	ADAPTHEALTH NEW ENGLAND LLC, a Delaware limited liability company
	ADAPTHEALTH PATIENT CARE SOLUTIONS LLC, a Pennsylvania limited liability company
	ADVOCATE MEDICAL SERVICES, LLC a Florida limited liability company
	AIRCARE HOME RESPIRATORY, LLC, a California limited liability company
	ALL AMERICAN HOME AID, LLC, a Massachusetts limited liability company
	AMERICAN ANCILLARIES, INC., a Nevada corporation
	AMERICOAST MARYLAND LLC, a Delaware limited liability company
	ASSOCIATED HEALTHCARE SYSTEMS, INC., a New York corporation
	BENNETT MEDICAL SERVICES LLC, a Nevada limited liability company
	BRADEN PARTNERS, L.P., a California limited partnership
	CHAMPLAIN VALLEY BRACE AND LIMB, L.L.C., a New York limited liability company
	CHOICE MEDICAL HEALTH CARE, LLC, an Illinois limited liability company
	CLEARVIEW MEDICAL INCORPORATED, a Texas corporation

	By:	/s/ Christopher J. Joyce
	Name:	Christopher J. Joyce
	Title:	Vice President and Secretary

[SIGNATURE PAGES CONTINUE]

ADAPTHEALTH LLC
CONSENT AGREEMENT

GUARANTORS (CONTINUED):	CPAP2ME, INC., a Delaware corporation
	DM ACQUISITION SUB LLC, a Delaware limited liability company
	FAMILY HOME MEDICAL SUPPLY LLC, a Pennsylvania limited liability company
	FAMIL SUPPLY, LLC, a North Carolina limited liability company
	FIRST CHOICE DME LLC, a Delaware limited liability company
	FIRST CHOICE HOME MEDICAL EQUIPMENT, LLC, a Delaware limited liability company
	FLORIDA HOME MEDICAL SUPPLY, LLC, a Florida limited liability company
	GOULD’S DISCOUNT MEDICAL, LLC, a Kentucky limited liability company
	HALPRIN, INCORPORATED, a New York corporation HEALTH SOLUTIONS LLC, a Pennsylvania limited liability company
	HEALTHLINE MEDICAL EQUIPMENT, LLC, a Texas limited liability company
	HOME MEDICAL EXPRESS, INC., an Illinois corporation
	HOME MEDISERVICE, LLC, a Maryland limited liability company
	HOME WELLNESS, LLC, a New Jersey limited liability company
	HOMETOWN HOME HEALTH, LLC, a Delaware limited liability company
	HUEY’S HOME MEDICAL, LLC, a Delaware limited liability company
	J.M.R. MEDICAL, LLC, a Delaware limited liability company
	LMI DME HOLDINGS LLC, a Delaware limited liability company
	M.A.R.Y. MEDICAL, LLC, a California limited liability company

	By:	/s/ Christopher J. Joyce
	Name:	Christopher J. Joyce
	Title:	Vice President and Secretary

[SIGNATURE PAGES CONTINUE]

ADAPTHEALTH LLC
CONSENT AGREEMENT

GUARANTORS (CONTINUED):	MED STAR SURGICAL & BREATHING EQUIPMENT INC., a New York corporation MED WAY MEDICAL, INC., a Utah corporation MED-EQUIP, INC., a Pennsylvania corporation MEDBRIDGE HOME MEDICAL LLC, a Delaware limited liability company
	MEDIDEX LLC, a Missouri limited liability company MEDSTAR HOLDINGS LLC, a Delaware limited liability company
	NRE HOLDING LLC, a Delaware limited liability company
	OCEAN HOME HEALTH OF PA LLC, a Pennsylvania limited liability company
	OCEAN HOME HEALTH SUPPLY LLC, a New Jersey limited liability company
	OGLES OXYGEN, LLC, a South Carolina limited liability company
	ORBIT MEDICAL OF PORTLAND, INC., a Utah corporation
	PAL-MED, LLC, a South Carolina limited liability company
	PALMETTO OXYGEN, LLC, a South Carolina limited liability company
	PPS HME HOLDINGS LLC, a Delaware limited liability company
	PPS HME LLC, a Delaware limited liability company RELY MEDICAL SUPPLY, LLC, a Colorado limited liability company
	ROBERTS HOME MEDICAL, LLC, a Maryland limited liability company
	ROYAL MEDICAL SUPPLY INC., a New Jersey corporation

	By:	/s/ Christopher J. Joyce
	Name:	Christopher J. Joyce
	Title:	Vice President and Secretary

[SIGNATURE PAGES CONTINUE]

ADAPTHEALTH LLC
CONSENT AGREEMENT

GUARANTORS (CONTINUED):	SENIOR CARE SERVICE, LLC, a Colorado limited liability company
	SKORO ENTERPRISES, LLC, a Texas limited liability company
	SLEEPEASY THERAPEUTICS, INC., a North Dakota corporation
	SLEEP THERAPY, LLC, a Minnesota limited liability company
	SOLARA HOLDINGS, LLC, a Delaware limited liability company
	SOLARA INTERMEDIATE, LLC, a Delaware limited liability company
	SOLARA MEDICAL SUPPLIES, LLC, a California limited liability company
	SOUND OXYGEN SERVICE LLC, a Washington limited liability company
	TOTAL RESPIRATORY, LLC, a Delaware limited liability company
	TRICOUNTY MEDICAL EQUIPMENT AND SUPPLY, LLC, a Pennsylvania limited liability company
	VERUS HEALTHCARE LLC, a Delaware limited liability company
	VERUS HEALTHCARE, INC., a Delaware corporation

	By:	/s/ Christopher J. Joyce
	Name:	Christopher J. Joyce
	Title:	Vice President and Secretary

[SIGNATURE PAGES CONTINUE]

ADAPTHEALTH LLC
CONSENT AGREEMENT

GUARANTORS (CONTINUED):	AEROCARE HOLDINGS LLC, a Delaware limited liability company
	ACCUCARE MEDICAL EQUIPMENT, LLC, an Oklahoma limited liability company
	AEROCARE HOME MEDICAL EQUIPMENT, INC., a Missouri corporation
	AEROCARE HOME MEDICAL EQUIPMENT, INC., a Texas corporation
	AEROCARE HOME MEDICAL, INC., a Texas corporation
	AEROCARE, INC., a Nevada corporation
	AEROCARE PHARMACY, INC., a Texas corporation ALL AMERICAN OXYGEN, INC., a Kentucky corporation
	ALLCARE, INC., a Colorado corporation
	BEACON RESPIRATORY SERVICES, INC., a Delaware corporation
	CARE PLUS OXYGEN, INC., a Pennsylvania corporation
	AEROCARE EXPRESS MEDICAL, LLC, a Delaware limited liability company
	EXPRESS MEDICAL SUPPLY, LTD., a Texas limited partnership
	FREEDOM RESPIRATORY, INC., a Virginia corporation
	HOME RESPIRATORY SOLUTION’S, INC., a Florida corporation
	PAUL HOME OXYGEN SERVICES, INC., a Colorado corporation
	PROMISE MEDICAL, INC., a Texas corporation
	SOUTHERN HOME RESPIRATORY & EQUIPMENT, INC., a Virginia corporation

	By:	/s/ Christopher J. Joyce
	Name:	Christopher J. Joyce
	Title:	Vice President and Secretary

[SIGNATURE PAGES CONTINUE]

ADAPTHEALTH LLC
CONSENT AGREEMENT

GUARANTORS (CONTINUED):	THE 3700 COMPANY, L.L.C., a Colorado limited liability company
	TWIN RIVERS RESPIRATORY CARE, INC., an Arkansas corporation
	SUNBELT MEDICAL SUPPLY & OXYGEN, INC., a Florida corporation
	PHARMACY, INC. KENTUCKY, a Kentucky corporation
	PHARMACY, INC., a Delaware corporation
	BEACON RESPIRATORY SERVICES OF GEORGIA, INC., a Delaware corporation
	LOVELL MEDICAL SUPPLY, INC., a North Carolina corporation
	TRINITY HEALTHCARE OF WINSTON-SALEM, INC., a Georgia corporation
	M. DAVIS MANAGEMENT, INC., a Florida corporation OXYGEN & SLEEP ASSOCIATES, INC., a Tennessee corporation
	ALL AMERICAN MEDICAL SERVICES, INC., a Florida corporation
	CHARLOTTE RESPIRATORY SOLUTIONS INC., a North Carolina corporation
	AEROCARE EMPLOYEE BENEFITS, INC., a Florida corporation
	LAMAR, LLC, a Florida limited liability company SKINNY LLC, a Florida limited liability company RESPIRATORY HOME CARE OF BRISTOL, LLC, a Tennessee limited liability company
	GUARDIAN MEDICAL INC, a Florida corporation DESLOGE HOME OXYGEN AND MEDICAL EQUIPMENT, INC., a Florida corporation
	RELIABLE MEDICAL OF CONWAY, LLC, a South Carolina limited liability company
	RELIABLE MEDICAL EQUIPMENT, LLC, a South Carolina limited liability company
	PATIENTS FIRST MEDICAL EQUIPMENT OF
	SPARTANBURG, LLC, a South Carolina limited liability company

	By:	/s/ Christopher J. Joyce
	Name:	Christopher J. Joyce
	Title:	Vice President and Secretary

[SIGNATURE PAGES CONTINUE]

ADAPTHEALTH LLC
CONSENT AGREEMENT

GUARANTORS (CONTINUED):	HOMETOWN RESPIRATORY CONSULTANTS, INC., a Tennessee corporation
	LOUISVILLE O 2, INC., a Kentucky corporation
	TRIAD RESPIRATORY SOLUTIONS, INC., a North Carolina corporation
	BIRD & BEAR MEDICAL, INC., an Arkansas corporation
	CPAPSUPPLY.COM, INC., a Texas corporation
	THE OXYGEN COMPANY, INC., a Virginia corporation
	GEORGIA HOME MEDICAL, INC., a Georgia corporation
	GEORGIA HOME MEDICAL - COLUMBUS, INC., a Georgia corporation
	EDGE MEDICAL SUPPLY, L.L.C., a Texas limited liability company
	BJ’S WHEELCHAIR SERVICE, INC., a Texas corporation
	T C MEDICAL SUPPLY, LLC, a Florida limited liability company
	MCFARLAND GROUP, INC., a Tennessee corporation
	ATLANTIC MEDICAL SUPPLY, INC., a Florida corporation
	TOTAL HOMECARE CORPORATION, a Virginia corporation
	ADMECO, INC., a Florida corporation
	RESPRACARE, INC., a North Carolina corporation
	MATRIX MEDICAL, LLC, a Florida limited liability company
	F1RST CHOICE IN-HOMECARE, INC., a Virginia corporation
	AMERICAN PREFERRED HOME MEDICAL, L.L.C., a Texas limited liability company
	DREAM CARE OF VIRGINIA, LLC, a Virginia limited liability company
	SOUTHERN NEVADA OXYGEN, INC., a Nevada corporation

	By:	/s/ Christopher J. Joyce
	Name:	Christopher J. Joyce
	Title:	Vice President and Secretary

[SIGNATURE PAGES CONTINUE]

ADAPTHEALTH LLC
CONSENT AGREEMENT

GUARANTORS (CONTINUED):	CARMICHAELS HOME MEDICAL EQUIPMENT, INC., a Georgia corporation
	LOOKOUT MEDICAL SERVICES, INC., a Tennessee corporation
	RESP-I-CARE, INC., a Tennessee corporation
	HEALTH PRODUCTS PLUS, INC., a Georgia corporation
	HOME NURSING CARE, INC., a Virginia corporation CHOICE RESPIRATORY & MEDICAL EQUIPMENT, INC., a Virginia corporation
	ATLANTIC MEDICAL, INC., a Virginia corporation CLAY HOME MEDICAL, INC., a Virginia corporation AMERI-QUIPT OF NORTH CAROLINA, INC., a North Carolina corporation
	AIRCARE HOME MEDICAL, INC., a Kentucky corporation
	AMERICAN HOME MEDICAL, INC., a Florida corporation
	FIRST CHOICE MEDICAL EQUIPMENT, INC., an Illinois corporation
	LOFTIS HOME MEDICAL, LLC, a North Carolina limited liability company
	MADISON COUNTY MEDICAL EQUIPMENT, INC., an Iowa corporation
	LEHIGH VALLEY RESPIRATORY CARE - LANCASTER, INC., a Pennsylvania corporation PEACH HOME HEALTH CARE, INC., a Georgia corporation
	MEDWAY MEDICAL EQUIPMENT, LLC, a Texas limited liability company
	MME II, LLC, a Texas limited liability company
	PREMIER HOME CARE, INC., a Kentucky corporation FLORIDA HOME CAIR, INC., a Florida corporation

	By:	/s/ Christopher J. Joyce
	Name:	Christopher J. Joyce
	Title:	Vice President and Secretary

[SIGNATURE PAGES CONTINUE]

ADAPTHEALTH LLC
CONSENT AGREEMENT

GUARANTORS (CONTINUED):	LCM MEDICAL, INC., a Florida corporation
	BESTMED RESPIRATORY, INC., an Iowa corporation BUYPAPUSA.COM, INC., an Oregon corporation HURST MEDICAL EQUIPMENT, INC., a West Virginia corporation
	PARRISH HOME MEDICAL, INC., a South Carolina corporation
	QUALITY RESPI-CARE, INC., a Georgia corporation MEDICAL NECESSITIES AND SERVICES, LLC, a Tennessee limited liability company
	KENTUCKY MEDICAL SUPPLY, INC., a Kentucky corporation
	AUSTIN RESPIRATORY EQUIPMENT, INC., a Florida corporation
	HOME CARE MEDICAL, INC., a Wisconsin corporation CORNERSTONE MEDICAL SERVICES OF COLUMBUS LLC, an Ohio limited liability company CORNERSTONE MEDICAL SERVICES -- MIDWEST, LLC, an Ohio limited liability company
	LEGACY MEDICAL LLC, an Ohio limited liability company
	HEARTLAND MEDICAL EQUIPMENT, INC., a Missouri corporation
	B-PHARM, INC., a Missouri corporation
	GME MEDICAL SUPPLY, INC., a Virginia corporation TRICOREX, INC., a Missouri corporation
	GRACE MEDICAL, INC., a Florida corporation WOLF INDUSTRIES, INC., a Mississippi corporation GRACE HEALTHCARE DME INC., a Mississippi corporation
	GRACE HEALTHCARE, INC., a Mississippi corporation

	By:	/s/ Christopher J. Joyce
	Name:	Christopher J. Joyce
	Title:	Vice President and Secretary

[SIGNATURE PAGES CONTINUE]

ADAPTHEALTH LLC
CONSENT AGREEMENT

GUARANTORS (CONTINUED):	GRACE HEALTHCARE INTERNET SALES, INC., a Mississippi corporation
	GRACE HEALTHCARE MEDICAL, INC., a Mississippi corporation
	GRACE MEDICAL EQUIPMENT INC, an Alabama corporation
	GRACE HEALTHCARE INCORPORATED, a Louisiana corporation
	MISSISSIPPI HMA DME, LLC, a Mississippi limited liability company
	PRATTVILLE MEDICAL EQUIPMENT INC., an Alabama corporation
	MONTGOMERY MEDICAL SUPPLY, INC., an Alabama corporation
	MEDLOGIC BIRMINGHAM INC., an Alabama corporation
	MEDLOGIC ANNISTON INC, an Alabama corporation MEDICAL LOGIC, INC., an Alabama corporation MEDICAL LOGIC FT. WALTON, INC., an Alabama corporation
	BREATHE GRACE MEDICAL SUPPLY, LLC, a Maryland limited liability company
	VITACARE, L.L.C. an Oklahoma limited liability company
	ABC MEDICAL, LLC, a South Carolina limited liability company
	MEDHOME SPECIALTY SERVICES, LLC, a Mississippi limited liability company
	OURS CORPORATION, an Illinois corporation
	IV CARE, LLC, a Missouri limited liability company ROCKY MOUNTAIN MEDICAL EQUIPMENT, INC., a Colorado corporation
	ROCKY MOUNTAIN MEDICAL EQUIPMENT LLC, a Colorado limited liability company
	MAJOR MEDICAL SUPPLY, LLC, a Colorado limited liability company
	MAJOR MEDICAL SUPPLY OF DENVER, LLC, a Colorado limited liability company

	By:	/s/ Christopher J. Joyce
	Name:	Christopher J. Joyce
	Title:	Vice President and Secretary

[SIGNATURE PAGES CONTINUE]

ADAPTHEALTH LLC
CONSENT AGREEMENT

GUARANTORS (CONTINUED):	MAJOR MEDICAL SUPPLY OF FORT COLLINS, LLC, a Colorado limited liability company
	MAJOR MEDICAL SUPPLY OF BRIGHTON LLC, a Colorado limited liability company
	MAJOR MEDICAL SUPPLY OF COLORADO SPRINGS LLC, a Colorado limited liability company MAJOR MEDICAL SUPPLY OF GREELEY LLC, a Colorado limited liability company
	PVHS HOME MEDICAL SUPPLY, LLC, a Colorado limited liability company
	COMMUNITY MEDICAL SUPPLY, INC., an Iowa corporation
	OXYGEN ONE, INC., a Wisconsin corporation QUALITY MEDICAL SERVICES, INC., an Iowa corporation
	MANOR RESPIRATORY CARE, INC., a Tennessee corporation
	SPECIALIZED MEDICAL DEVICES, INC., an Alabama corporation
	DESERT RIDGE REHABILITATION & HEALTH CENTER LLC, an Arizona limited liability company THH ACQUISITION LLC I, a Delaware limited liability company
	AIRWAY OXYGEN, INC., a Michigan corporation BHS, INC., a Kentucky corporation
	HUB’S HOME OXYGEN & MEDICAL SUPPLIES, INC., a Pennsylvania corporation
	CRESSCARE MEDICAL, INC., a Pennsylvania corporation
	BLUEGRASS OXYGEN, INC., a Kentucky corporation NEW ENGLAND HOME MEDICAL EQUIPMENT, LLC, a Massachusetts limited liability company

	By:	/s/ Christopher J. Joyce
	Name:	Christopher J. Joyce
	Title:	Vice President and Secretary

[SIGNATURE PAGES CONTINUE]

ADAPTHEALTH LLC
CONSENT AGREEMENT

GUARANTORS (CONTINUED):	DIABETES SUPPLY CENTER OF THE MIDLANDS, LLC, a Nebraska limited liability company
	LEGACY HOMEMEDICAL LLC, a Utah limited liability company
	PINNACLE MEDICAL SOLUTIONS, LLC, a Mississippi limited liability company
	DIABETES MANAGEMENT AND SUPPLIES, L.L.C., a Louisiana limited liability company
	DIABETES MANAGEMENT PHARMACY, L.L.C., a Louisiana limited liability company
	ABSOLUTE RESPIRATORY CARE, LLC, a Delaware limited liability company
	ACCESS MEDICAL, LLC, a Michigan limited liability company
	ADAPTHEALTH MINNESOTA LLC, a Minnesota limited liability company
	AGILE MEDICAL, LLC, a Pennsylvania limited liability company
	AGILIS MED HOLDINGS, LLC, a Delaware limited liability company
	AMERICA’S HEALTH CARE AT HOME, LLC, a Delaware limited liability company
	BRADLEY DME, LLC, a Tennessee limited liability company
	BUFFALO WHEELCHAIR, INC., a New York corporation
	CAPE MEDICAL SUPPLY, LLC, a Delaware limited liability company
	ELLIS HOME OXYGEN & MEDICAL EQUIPMENT, INC., a Virginia corporation
	HEALTH COMPLEX MEDICAL, LLC, a Delaware limited liability company

	By:	/s/ Christopher J. Joyce
	Name:	Christopher J. Joyce
	Title:	Vice President and Secretary

[SIGNATURE PAGES CONTINUE]

ADAPTHEALTH LLC
CONSENT AGREEMENT

GUARANTORS (CONTINUED):	HEALTHY LIVING MEDICAL SUPPLY, LLC, a Michigan limited liability company
	LIFEHME, INC., a South Carolina corporation OLYMPIA RESPIRATORY SERVICES, LLC, a Washington limited liability company
	OXYGEN SUPPLY SHOP L.L.C., a New Jersey limited liability company
	PROVIDER PLUS, INC., a Missouri corporation QUALITY HOME MEDICAL, INC., a South Carolina corporation
	SPIRO HEALTH SERVICES, LLC, a Delaware limited liability company
	TMS VT, LLC, a Delaware limited liability company VERIO HEALTHCARE, INC., a California corporation WECARE MEDICAL, LLC, a Kentucky limited liability company
	WECARE MEDICAL SOMERSET, LLC, a Kentucky limited liability company
	RESPIRATORY SERVICES OF WESTERN NEW YORK, INC., a New York corporation

	By:	/s/ Christopher J. Joyce
	Name:	Christopher J. Joyce
	Title:	Vice President and Secretary

[SIGNATURE PAGES CONTINUE]

ADAPTHEALTH LLC
CONSENT AGREEMENT

ADMINISTRATIVE AGENT
AND COLLATERAL AGENT:	REGIONS BANK

	By:	/s/ Brian Walsh
	Name:	Brian Walsh
	Title:	Director

ADAPTHEALTH LLC
CONSENT AGREEMENT

LENDERS:	REGIONS BANK

	By:	/s/ Brian Walsh
	Name:	Brian Walsh
	Title:	Director

	CITIZENS BANK, N.A.

	By:	/s/ Mark Guyeski
	Name:	Mark Guyeski
	Title:	Vice President

	FIFTH THIRD BANK, NATIONAL ASSOCIATION

	By:	/s/ John McChesney
	Name:	John McChesney
	Title:	Director, VP

	JPMORGAN CHASE BANK, N.A.

	By:	/s/ David Hyman
	Name:	David Hyman
	Title:	Executive Director

	KEYBANK NATIONAL ASSOCIATION

	By:	/s/ Tanille Ingle
	Name:	Tanille Ingle
	Title:	Vice President

	TRUIST BANK

	By:	/s/ Anton Brykalin
	Name:	Anton Brykalin
	Title:	Director

	FIRST-CITIZENS BANK & TRUST COMPANY (successor by merger to CIT Bank, N.A.)

	By:	/s/ Andres Alev
	Name:	Andres Alev
	Title:	Director

	DEUTSCHE BANK AG NEW YORK BRANCH

	By:	/s/ Philip Tancorra
	Name:	Philip Tancorra
	Title:	Vice President

	By:	/s/ Ian Dorrington
	Name:	Ian Dorrington
	Title:	Managing Director

ADAPTHEALTH LLC
CONSENT AGREEMENT

LENDERS (CONTINUED):	HANCOCK WHITNEY BANK

	By:	/s/ Megan Brearey
	Name:	Megan Brearey
	Title:	Senior Vice President

	ROYAL BANK OF CANADA

	By:	/s/ Mustafa Topiwalla
	Name:	Mustafa Topiwalla
	Title:	Authorized Signatory

	M&T BANK, successor by merger to PEOPLE’S UNITED BANK, N.A.

	By:	/s/ Donna J. Emhart
	Name:	Donna J. Emhart
	Title:	Senior Vice President

	BANCALLIANCE INC

	By:	Alliance Partners LLC, its Attorney-in Fact

	By:	/s/ John Gray
	Name:	John Gray
	Title:	Executive Vice President

	BANKUNITED, N.A.

	By:	/s/ Thomas Feifar, 5/6/2022
	Name:	Thomas Feifar, 5/6/2022
	Title:	Vice President, Authorized Signor

	FIRST MIDWEST BANK

	By:	/s/ Anne-Christine Day
	Name:	Anne-Christine Day
	Title:	Assistant Vice President

	BANK OF AMERICA, N.A.

	By:	/s/ Irina Froment
	Name:	Irina Froment
	Title:	Senior Vice President

ADAPTHEALTH LLC
CONSENT AGREEMENT

LENDERS (CONTINUED):	CAPITAL ONE, NATIONAL ASSOCIATION

	By:	/s/ Karen M Dahlquist
	Name:	Karen M Dahlquist
	Title:	Duly Authorized Signature

	FIRST HORIZON BANK

	By:	/s/ Sameer Gupta
	Name:	Sameer Gupta
	Title:	Managing Director

	SYNOVUS BANK

	By:	/s/ Michael Sawicki
	Name:	Michael Sawicki
	Title:	Director

	UBS AG, STAMFORD BRANCH

	By:	/s/ Dionne Robinson
	Name:	Dionne Robinson
	Title:	Associate Director

	By:	/s/ Anthony N Joseph
	Name:	Anthony N Joseph
	Title:	Associate Director


	BANK OF THE WEST

	By:	/s/ Michael Weinert
	Name:	Michael Weinert
	Title:	Managing Director

ADAPTHEALTH LLC
CONSENT AGREEMENT

EX-101.SCH 3 ahco-20220510.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 ahco-20220510_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 ahco-20220510_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT

Cover	May 09, 2022
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	May 09, 2022
Entity File Number	001-38399
Entity Registrant Name	AdaptHealth Corp.
Entity Central Index Key	0001725255
Entity Tax Identification Number	82-3677704
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	220 West Germantown Pike
Entity Address, Address Line Two	Suite 250
Entity Address, City or Town	Plymouth Meeting
Entity Address, State or Province	PA
Entity Address, Postal Zip Code	19462
City Area Code	610
Local Phone Number	630-6357
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	AHCO
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	false

XML 7 tm2215133d2_8k_htm.xml IDEA: XBRL DOCUMENT 0001725255 2022-05-09 2022-05-09 iso4217:USD shares iso4217:USD shares 0001725255 false 8-K 2022-05-09 AdaptHealth Corp. DE 001-38399 82-3677704 220 West Germantown Pike Suite 250 Plymouth Meeting PA 19462 610 630-6357 false false false false Common Stock, par value $0.0001 per share AHCO NASDAQ false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://adapthealth.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tm2215133d2_8k.htm ahco-20220510.xsd ahco-20220510_lab.xml ahco-20220510_pre.xml tm2215133d2_ex10-1.htm http://xbrl.sec.gov/dei/2021q4 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tm2215133d2_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "tm2215133d2_8k.htm" ] }, "labelLink": { "local": [ "ahco-20220510_lab.xml" ] }, "presentationLink": { "local": [ "ahco-20220510_pre.xml" ] }, "schema": { "local": [ "ahco-20220510.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "ahco", "nsuri": "http://adapthealth.com/20220510", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2215133d2_8k.htm", "contextRef": "From2022-05-09to2022-05-09", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://adapthealth.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2215133d2_8k.htm", "contextRef": "From2022-05-09to2022-05-09", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" } }, "version": "2.1" } ZIP 14 0001104659-22-059497-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-22-059497-xbrl.zip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end